Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sanofi-Aventis Deutschland GmbH
FDA Inspection
•Sanofi-Aventis Deutschland GmbH•March 3, 2017

Sanofi-Aventis Deutschland GmbH – FDA Inspection, Mar 3, 2017

Record Details

This FDA Inspection record concerns Sanofi-Aventis Deutschland GmbH, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Sanofi-Aventis Deutschland GmbH
Inspection Date
March 3, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Junho Pak (FDA Associated Person)
View Company Profile

ID · c34bec9c-4453-44d0-bcba-d9df811b7c10

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1006001
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

5
  1. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  2. 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
  3. 21 CFR 211.113(b)Validation lacking for sterile drug products
  4. 21 CFR 211.192Written record of investigation incomplete
  5. 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sanofi-Aventis Deutschland GmbH

11
DateClassificationOfficeProject area
January 16, 2025Not classifiedOffice of Inspections and Investigations
March 25, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 14, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 10, 2015NAICenter for Devices and Radiological HealthCompliance: Devices
June 26, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page
Other documents for Sanofi-Aventis Deutschland GmbH
  • FDA Inspection 1262770 - 2025-01-16
  • FDA Inspection 1215824 - 2022-03-25
  • FDA Inspection 1094836 - 2019-05-14
  • FDA Inspection 952968 - 2015-12-10
  • FDA Inspection 933399 - 2015-06-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sanofi-Aventis Deutschland GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.